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Highlights
 Soil samples around landfill waste sites were screened for
their ability to activate xenobiotic receptors and toxicity.
 Xenoestrogens were present at higher levels in soils around a
landfill site.
 An ionic liquid was found to be present at high levels in two
soil sampling sites near landfill.
 The ionic liquid inhibited cellular oxidative phosphorylation,
was toxic to a liver progenitor cell line and induced
apoptosis.
 The ionic liquid was metabolised by human hepatocytes to a
carboxylic acid that bore structural similarity to lipoic acid.
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Lay summary
Primary biliary cholangitis is a liver
disease in which most patients have
antibodies to mitochondrial proteins
containing lipoic acid binding site(s). This
paper identified a man-made chemical
present in soils around a waste site. It was
then shown that this chemical was
metabolized into a product with
structural similarity to lipoic acid, which
was capable of replacing lipoic acid in
mitochondrial proteins.
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Background & Aims: Primary biliary cholangitis (PBC) is an
autoimmune-associated chronic liver disease triggered by envi-
ronmental factors, such as exposure to xenobiotics, which leads
to a loss of tolerance to the lipoic acid-conjugated regions of the
mitochondrial pyruvate dehydrogenase complex, typically to
the E2 component. We aimed to identify xenobiotics that might
be involved in the environmental triggering of PBC.
Methods: Urban landfill and control soil samples from a region
with high PBC incidence were screened for xenobiotic activities
using analytical, cell-based xenobiotic receptor activation
assays and toxicity screens.
Results: A variety of potential xenobiotic classes were ubiqui-
tously present, as identified by their interaction with xenobiotic
receptors – aryl hydrocarbon receptor, androgen receptor and
peroxisome proliferator activated receptor alpha – in cell-
based screens. In contrast, xenoestrogens were present at higher
levels in soil extracts from around an urban landfill. Further-
more, two landfill sampling sites contained a chemical(s) that
inhibited mitochondrial oxidative phosphorylation and induced
the apoptosis of a hepatic progenitor cell. The mitochondrial
effect was also demonstrated in human liver cholangiocytes
from three separate donors. The chemical was identified as
the ionic liquid [3-methyl-1-octyl-1H-imidazol-3-ium]+
(M8OI) and the toxic effects were recapitulated using authentic
pure chemical. A carboxylate-containing human hepatocyte
metabolite of M8OI, bearing structural similarity to lipoic acid,
was also enzymatically incorporated into the E2 component of
the pyruvate dehydrogenase complex via the exogenous lipoy-
lation pathway in vitro.
Conclusions: These results identify, for the first time, a xenobi-
otic in the environment that may be related to and/or be a com-
ponent of an environmental trigger for PBC. Therefore, further
study in experimental animal models is warranted, to deter-
mine the risk of exposure to these ionic liquids.
Lay summary: Primary biliary cholangitis is a liver disease in
which most patients have antibodies to mitochondrial proteins
containing lipoic acid binding site(s). This paper identified a
man-made chemical present in soils around a waste site. It
was then shown that this chemical was metabolized into a pro-
duct with structural similarity to lipoic acid, which was capable
of replacing lipoic acid in mitochondrial proteins.
 2018 European Association for the Study of the Liver. Published by
Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
Introduction
Liver disease constitutes the third most common cause of pre-
mature death in the UK, with an upward trend in mortality.1,2
The major causes of liver disease such as obesity, viral infection
and chronic alcohol consumption are preventable. However, the
causes of rarer types of liver disease – such as primary biliary
cholangitis (PBC) and primary sclerosing cholangitis (PSC) are
unknown and as a consequence, prevention and/or treatments
are limited.3 A variety of factors have been linked to increased
incidence of PBC and PSC in populations. In both cases, although
there is a clear genetic pre-disposition,4,5 there is also evidence
that environmental factors – such as exposure to foreign com-
pounds (xenobiotics) – determine the likelihood of developing
disease.6–9
In the majority of cases, PBC is associated with an immuno-
logical loss of tolerance to the lipoic acid-conjugated regions of
the mitochondrial pyruvate dehydrogenase complex (PDC), also
known as dihydrolipoamide-S-acetyl transferase, leading to the
presence of high levels of diagnostic anti-mitochondrial anti-
bodies (AMA) in patient sera.10,11 Thus, one potential trigger
for PBC may be exposure to chemicals that structurally and
chemically mimic lipoic acid and may therefore be capable of
being enzymatically incorporated into the E2 component of
PDC (PDC-E2) in place of lipoic acid.10,11 Specific disease pathol-
ogy in the liver (since the antigen for AMA is present in most
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cells of the body) is thought to be due to selective exposure of
the neo-antigen (e.g. via selective apoptosis of hepatic intrahep-
atic duct cells/cholangiocytes).12
A number of signaling pathways have been identified in cells
that function to detect xenobiotics and modulate gene expres-
sion in order to facilitate their metabolism and excretion. Poly-
cyclic aromatic hydrocarbons (PAHs) are environmental organic
xenobiotics consisting of two or more clustered benzene rings,
which are present in crude oil and coal tar and contaminate
the environment through fossil fuel burning, incineration of
waste and other industrial processes.13 They are hydrophobic
and often persist in the environment and tissues. Many PAHs
are suspected or known to be toxic, genotoxic and carcino-
genic.14 The aryl hydrocarbon receptor (AHR) binds and is tran-
scriptionally activated by many PAHs.15 In the liver, this leads to
the increased expression of a variety of genes associated with
xenobiotic metabolism (e.g. the AHR locus).15 However, the
function of the AHR likely extends beyond xenobiotic metabo-
lism alone as its endogenous functions appear to include roles
in the immune system.16 In the thymus, AHR activation can lead
to thymocyte apoptosis and thymic atrophy.17
The peroxisome proliferator activated receptor alpha
(PPARa) is a nuclear receptor that functions in the regulation
of fatty acid oxidation. In addition to its activation by selected
endogenous lipids, the receptor is also activated by fibrate drugs
(its pharmacological target) and xenobiotics such as polyhalo-
genated chemicals e.g. perfluorooctane sulfonate.18 The nuclear
estrogen receptor alpha (ERa) appears to be a frequent target
for a variety of natural (e.g. plant phytoestrogens) and xenobi-
otic man-made chemicals (e.g. pesticides). It has been proposed
that xenoestrogens are responsible for a spectrum of adverse
effects in wildlife and man that include malformations in the
male genital tract; decreased sperm quality; neuroendocrino-
logical, behavioral and metabolic effects and cancer.19–21
In an attempt to identify potential environmental xenobiotic
triggers, urban landfill and control soil samples from a region
with high PBC incidence were screened for xenobiotic activities
using a variety of in vitro cell-based assays.
Materials and methods
Chemicals
3-Methyl-1-octyl-1H-imidazol-3-ium (M8OI) was purchased
from Sigma (Poole, UK). 1-(8-Hydroxyoctyl)-3-methyl-imidazo
lium (HO8IM) and 1-(7-carboxyheptyl)-3-methyl-1H-imida
zol-3-ium (COOH7IM) were custom synthesized with purity
and chemical structures determined by high-performance liquid
chromatography (HPLC), mass spectrometry and nuclear mag-
netic resonance techniques (NMR) (for COOH7IM, see Fig. S11).
Preparation of soil extracts
Surface soil samples (0–5 cm in depth) were collected and
extraneous vegetable matter and stones removed. Each sample
was divided into four 250 g portions. A sample of one portion
was digested using aqua regia in accordance with BS7755 for
metals analysis. Two portions were subjected to either metha-
nol (for polar molecule) or chloroform (for hydrophobic chemi-
cal) extractions by sonicating with 300 ml of solvent for 10 min,
followed by addition of a further 100 ml of solvent and sonica-
tion for a further 10 min prior to filtration with 25 lm filters
and collection of filtrate. Filtrates were evaporated in a rotary
evaporator and then blown down to near dryness under a
stream of nitrogen. The methanol extracted material was
divided into two and added to either 10 ml of phosphate buf-
fered saline (PBS, 137 mM NaCl, 27 mM KCl, 100 mM phosphate
pH 7.4) or 10 ml of ethanol. The chloroform extracted material
was re-dissolved into 10 ml of chloroform. The solvated
extracted chemicals were then separated from any precipitate
and stored at 20 C (ethanol and chloroform extracts) or 4 C
(PBS extracts).
Thirteen soil samples were collected from allotments, foot-
paths and the roadside verges surrounding an urban landfill site.
Three control soil samples were collected from three separate
sites. One sample was obtained from the University farm in
rural Northumberland at a site with controlled fertilizer regime
for the last 130 years. The remaining two control samples were
obtained from gardens in urban areas in the region.
Cell culture
Rat B-13 hepatocyte progenitor cells were routinely expanded
in low glucose (1000 mg/l) Dulbecco’s minimum essential med-
ium (DMEM) supplemented with 10% (v/v) fetal calf serum
(FCS), 80 u/ml penicillin and 80 lg/ml streptomycin. B-13 cells
were converted into functional hepatocytes (B-13/H cells)
in vitro through addition of 10 nM dexamethasone, essentially
as previously outlined.52,53,23 B-13/H cells are a non-
proliferative functional hepatocyte-like cell expressing a variety
of hepatic functions (such as functional cytochrome P450s) at
near normal liver levels.54 The human H69 cholangiocyte cell
line55 was routinely expanded in 3:1 (v/v) ratio of DMEM and
Nutrient F12 Ham’s medium supplemented with 180 lM ade-
nine, 2 nM triiodothyronine, 5.5 lM epinephrine, 1 lM hydro-
cortisone, 10% v/v FCS, 1 insulin/transferrin/selenium (Gibco)
and 1 Pen/Strep (Lonza). The human hepatoma HepG2 cell line
was cultured as previously described.56 The human breast can-
cer MCF-7 cell line was cultured as previously described.57 All
cells were incubated at 37 C in a humidified incubator gassed
with 5% CO2 in air. Human cholangiocytes were isolated from
resected human liver using an immune-bead approach as previ-
ously described and cultured in 1:1 [v/v] DMEM:Hams F12
medium supplemented with 10% (v/v) FBS, 2 mM glutamine,
100 IU/ml penicillin, 100 lg/ml streptomycin, 10 ng/ml epider-
mal growth factor (EGF), 0.248 IU/ml insulin, 2 lg/ml hydrocor-
tisone, 10 ng/ml cholera toxin, 2 nM tri-iodo-L-thyronine and
5 ng/ml hepatocyte growth factor (HGF).58 Human hepatocytes
were isolated from a 42-year-old male donor by collagenase
perfusion, essentially as previously described,59 and cultured
on collagen-coated plates in Williams medium E supplemented
with 10% (v/v) FCS, 80 IU/ml penicillin, 80 lg/ml streptomycin,
10 nM dexamethasone and 1 lg/ml insulin. After an overnight
culture period, the medium was aspirated, the cells were
washed three times with sterile PBS prior to incubation with
M8OI in a short-term simplified incubation medium (STIM buf-
fer: 0.10 M NaCl, 5.4 mM KCl, 0.34 mM Na2HPO4 12H2O,
0.44 mM KH2PO4, 20 mM glucose, 1 mM CaCl2, 40 mM NaHCO3,
4 mM glutamine, 100 lM L-alanine, 100 lM L-asparagine,
100 lM L-aspartic acid, 100 lM L-glutamic acid, 100 lM glycine,
100 lM L-proline and 100 lM L-serine, pH 7.4 when gassed with
5% CO2 in air) to minimize interference with M8OI detection,
typically 1.5 ml/well of a 6-well plate. As a control, M8OI was
incubated identically in a cell-free culture vessel. After 24 h,
the STIM incubation was removed, centrifuged at 13,000 rpm
for 1 min and 10 volumes of supernatant clear of any cellular
material retained and added to 1 volume 1% phosphoric acid.
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Acid-precipitated material was removed by centrifugation
(13,000 rpm, 1 min) and the supernatant was retained and
stored at 4 C prior to analysis. Human tissue was obtained with
patient consent and with approval of the Newcastle & North
Tyneside 2 Research Ethics Committee.
Animal study
A study with mice detailed in the supplementary data section
was performed under a UK Home Office license with Local
Ethics Committee approval. Animals (up to five per cage) were
housed in Maxiseal 420 cm2 mouse cages (Arrowmight, Here-
ford, UK) in an enriched environment (nesting material, chew
sticks and cardboard tubes) and were provided with food
(RM3 Special Diet Services, UK) and water ad libitum in an air-
conditioned environment on a 12 h light/dark cycle with regu-
lated humidity (50% ± 10%) and temperature (23 C ± 1 C). All
animals received humane care and the study was in compliance
with institutional and ARRIVE guidelines.
For further details regarding the materials and methods
used, please refer to the CTAT table and supplementary
information.
Results
Similar levels of heavy metals, polyaromatic hydrocarbons
and pesticides were present in landfill and control site soils
Soil samples were taken from around a currently active peri-
urban landfill site (and from three separate control sampling
sites), with all sites positioned upon an area of historic coal min-
ing. Extracts obtained using different solvents – from aqueous
to hydrophobic - were prepared and tested as schematically
outlined (Fig. S1A). Analysis of both sonicated soil extracts
and the aqua regia digests indicated low levels of contamination
with a wide range of potentially toxic elements (Table S1). At all
sample sites, values were typical of an urban soil lacking overt
contamination.22 These data were supported by a metalloth-
ionein luciferase reporter gene assay screen, which indicated
low levels of metals in all soil extracts (Fig. S1B). Since the land-
fill and control sites were also situated in a region with a history
of intensive coal mining, the soil levels of common PAHs were
also examined. The evidence indicates that levels were not sig-
nificantly different although overall, the mean levels were
higher in control soils (65 ± 54 mg/kg soil) compared to landfill
soils (13 ± 19 mg/kg soil) (Table S2). A screen for 24 different
pesticides indicated that 22 out of 24 were detectable in at least
one soil sample and a minimum of at least four different pesti-
cides (landfill soil sample 2) were detectable in each soil sample
(Table S3). In all samples, the levels were low with only two
pesticides - Diuron and Omethoate – present at levels greater
than 1 ppm in any soil extract (the former, at mean higher levels
in control soils compared to soils in close proximity to the land-
fill site). The combined mean pesticide levels were higher in
control soils (total of 3.9 ± 1.81 ppm) compared to soils in close
proximity to the landfill site (total of 2.0 ± 1.69 ppm).
To screen for the presence of acutely toxic chemicals,
extracts were screened for toxicity in hepatic progenitor B-13,
hepatocyte-like B-13/H and H69 cholangiocyte cell lines23 at
an initial concentration of 1% (v/v) in culture media. With the
exception of PBS solvated extracts from two landfill sampling
sites and B-13 cells – none of the extracts were markedly toxic
(Fig. S2). To reduce the potential that toxic effects might inter-
fere with signaling pathway interactions, a further 10-fold
dilution of soil extracts was routinely examined (i.e. 0.1% (v/v)
in culture media). We demonstrate that extracts from both
the landfill sampling sites and control sites induced several
hundred-fold increases in AHR-dependent XRE-luc reporter
gene activity (Fig. S3A), with higher fold induction observed in
extracts solvating more hydrophobic chemicals (i.e. chloroform
extracts). These data were confirmed by similar robust induc-
tion in AHR-regulated Cyp1a1 mRNA expression in
metabolically-active xenobiotic metabolizing B-13/H cells
(Fig. S3B); a dose-response effect in all selected tested extracts
(Fig. S3C) and induction of Cyp1a1 protein expression
(Fig. S3D). Similar results were also found when ethanol and
chloroform extracts were examined for activators of the human
PPARa (Fig. S4), demonstrating that soil extracts from both
landfill and control sites contain chemicals that activate xenobi-
otic receptor AHR and PPARa receptors.
Chemicals present in landfill site soils activated the human
ERa, with limited effects on the human AR
To determine whether soil extracts contained xenoestrogens
capable of activating the human ERa, MCF-7 cells transfected
with an estrogen responsive luciferase reporter gene (ERE3-
pGL3 promoter) were exposed to soil extracts. PBS and chloro-
form extracts were not toxic (Fig. S5A, B) and in a minority of
landfill soil samples, contained chemicals that activated the
human ERa (Fig. S5D, E). However, ethanol soil extracts – which
were not toxic to MCF-7 cells either (Fig. 1A), see also Fig. S5C –
contained the most potent ERa activation activities, with activa-
tion restricted to several soil samples in close proximity to a
landfill site (Fig. 1B). There was low to undetectable estrogenic
activity detectable in ethanol extracts from the control soil sam-
ples (Fig. 1B). Clear dose-responses were observed through fur-
ther dilution of ethanol extracts (Fig. 1C). Inhibition of
activation by co-incubation with the anti-estrogen ICI182780
(Fig. 1D) confirmed direct ERa interaction and activation of
transcriptional function by the ethanol extracts from soil sam-
ples in proximity to a landfill site. In contrast, there was limited
activity directed toward the human androgen receptor (AR)
with only control site 2 yielding a statistically significant
increase in reporter gene expression, which is likely not to be
of biological significance (Fig. 1E). Two landfill soil sites con-
tained chemicals capable of antagonizing dihydrotestosterone
activation of the human AR (Fig. 1F).
In contrast to AHR and PPARa-activating chemicals, these
data demonstrate that several extracts from sites close to a
landfill site contain human ERa-activating chemicals, which
were not present in control soil samples.
Two aqueous landfill soil extracts blocked hepatic progenitor
cell proliferation and induced cell death
PBS extracts from two sampling sites in close proximity to the
landfill site showed marked toxicity in the hepatic B-13 progen-
itor cell line (Fig. S2A) – with less sensitivity in the xenobiotic
metabolically-active B-13/H hepatocyte cell derived therefrom
(Fig. S2D). Since there was a lack of apparent sensitivity in
H69 (Fig. S2G) and MCF-7 cells (Fig. S5A), the nature of this tox-
icity was examined in the B-13 liver progenitor cell. The earliest
observed effects of PBS 1 and 2 extracts on B-13 cells was an
inhibition in proliferation, which was confirmed by marked
inhibition of DNA synthesis (Fig. 2A), initial inhibition in cell
numbers, and subsequent cell death between 24 h and 48 h
after exposure (Fig. 2B). A dose-response effect of the toxic
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Fig. 1. Soil samples in close proximity to a landfill site contain biologically active levels of ERa activating chemicals. (A) Determination of MTT reduction
in MCF-7 cells following 24 h incubation with 0.1% v/v ethanol extracts. Results are expressed as the mean and SD of three separate determinations and are
expressed as a percentage of 0.1% (v/v) ethanol vehicle. (B) Human ERa activation (ERE3-pGL3 promoter-Luc). MCF-7 cells were transfected with reporter
constructs and 24 h later, treated with 0.1% v/v of the ethanol extracts. After 24 h exposure, reporter gene activities were determined as outlined in the methods
section with data, the mean and SD of three separate transfections. (C) Dose-response effect for human ERa activation (ERE3-pGL3 promoter-Luc) in MCF-7 cells
treated with the indicated dilution of landfill waste site soil ethanol extract, expressed as fold ethanol vehicle control. Data are the mean and SD of three
separate determinations. (D) Human ERa activation (ERE3-pGL3 promoter-Luc). MCF-7 cells were transfected with reporter constructs and 18 h later, pre-
treated where indicated with the ERa antagonist ICI182780) or solvent vehicle control. After 6 h, cells were then treated with 0.1% (v/v) of the indicated ethanol
extracts. After 24 h exposure, reporter gene activities were determined as outlined in the methods section with data, the mean and SD of three separate
transfections. *Significantly different from solvent control (for soil extracts) or control vehicle for known chemicals (p < 0.05) using ANOVA/Bonferroni-Holm
comparison between groups or #equivalent extract in the absence of ICI (p < 0.05) using Student’s t test (two tailed). (E) Human AR activation (prostate C3
RE4-luciferase) activation by ethanol extracts. Reporter gene activities were determined as outlined in the methods section with data, the mean and SD of at
least three separate transfections. *Significantly different from solvent control (for soil extracts) or control vehicle for known chemicals (p < 0.05) using ANOVA/
Bonferroni-Holm comparison between groups. (F) Human AR activation (prostate C3 RE4-luciferase) antagonism by ethanol extracts after activation 500 pM
DHT. Reporter gene activities were determined as outlined in the methods section with data the mean and SD of at least three separate transfections.
Significantly different from #solvent control or *500 pM DHT (p < 0.05) using ANOVA/Bonferroni-Holm comparison between groups. AR, androgren receptor;
DHT, dihydrotestosterone; ER, estrogen receptor.
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PBS extracts on B-13 MTT reduction is demonstrated (Fig. 2C).
Since the cells excluded trypan blue after effects on proliferation
and MTT reduction, it was hypothesized that B-13 cells undergo
an apoptotic mechanism of cell death. PBS extracts 1 and 2
induced a marked increase in caspase 3/7 activity (Fig. 2D)
and cleavage of genomic DNA to generate classic nucleosomal
ladders (Fig. 2E), supporting an initial apoptotic mode of cell
death.
To further characterize the causative mechanism(s) inducing
B-13 cell apoptosis, the potential role of mitochondria was
examined, since this organelle plays a critical role in apoptotic
mechanisms of cell death. Replacing media glucose with galac-
tose has been reported to increase cellular susceptibility to
mitochondrial toxicants.24 It was demonstrated that replacing
glucose with galactose sensitized B-13 cells – in a dose respon-
sive manner – to the toxic effects of the toxic PBS extracts
(Fig. 3A). Measurements of oxygen consumption rates in B-13
cells using a seahorse analyzer confirm that the toxic PBS
extracts inhibited oxidative phosphorylation, targeting in par-
ticular maximal respiration and ATP production (Fig. 3B, C). B-
13/H mitochondria were less sensitive to the toxic PBS extracts,
experiencing weaker inhibitory effects on both maximal respi-
ration rate and ATP production (see Fig. S8A), supporting a role
for the mitochondrial effects of toxic PBS extracts in B-13 cell
death. Toxic PBS extract exposure resulted in a dose-
dependent decrease in oxygen consumption rate (OCR) and a
dose-dependent increase in extracellular acidification rate
(ECAR) in B-13 cells (Fig. 3D). The increase in ECAR was
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considered likely due to an inhibition of mitochondrial oxida-
tive phosphorylation and compensatory regulated changes in
metabolism such as glycolytic flux. This hypothesis was sup-
ported by decreases in cellular ATP in cells treated with toxic
PBS extracts when glucose was limited (Fig. 3E); a protection
from toxicity through increasing glucose concentration (data
not included) and an activation of AMP activated protein kinase
by phosphorylation, an effect not observed when cells were
treated in high glucose media (Fig. 3F).
These data indicate that the PBS extracts from two sampling
sites in close proximity to the landfill site contain a chemical(s)
that inhibited mitochondrial oxidative phosphorylation.
The landfill toxic PBS extracts inhibit cultured human
cholangiocyte mitochondrial function
To establish whether the toxic response of B-13 cells to toxic
PBS extracts could be relevant to man, cholangiocytes were iso-
lated from resected human liver and exposed to toxic PBS
extracts or control PBS, although limitations in tissue and cell
numbers precluded extensive analyses. The cells isolated from
three donors expressed the biliary marker cytokeratin 19,
confirming that an enriched population of cholangiocytes was
isolated and cultured (Fig. 4A). Application of the seahorse
approach to determine effects on OCR demonstrated that both
toxic PBS extracts inhibited mitochondrial function in a similar
manner to that observed in B-13 cells (Fig. 4B). Maximal
respiration and ATP production were also affected by the PBS
extracts, as observed with B-13 cells, additionally, basal respira-
tion rates were also inhibited (Fig. 4C).
Therefore, these limited analyses in human cholangiocytes
suggest that the adverse effects of the toxic PBS extracts could
be relevant in man if the ductular regions of the liver are
exposed to sufficient concentrations of the chemical(s).
The toxic chemical present in aqueous soil extracts from
near landfill was the ionic liquid 3-methyl-1-octyl-1H-
imidazol-3-ium+
PBS extracts from landfill sampling sites 1 and 2, were subjected
to thin-layer chromatography and spectrophotometry and
determined to be a non-fluorescent chemical(s) lacking
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extensive bond conjugation (Fig. S6A–C). The presence of bacte-
rial agents and/or toxic proteins was also excluded (Fig. S6D, E).
Exposing B-13 cells to separate HPLC fractions showed that the
toxic effects associated with the extracts co-eluted with the
major peak detected, which was not detectable in the control
and non-toxic landfill PBS extracts after identical batch fraction
collection (Fig. 5A). Mass spectrometric analyses of the material
eluting with this peak suggested the presence of a single species
corresponding to a singly charged [M+H] of 195.1861 Da
(Fig. 5B). Interrogation of databases predicted the best elemen-
tal fit to the parent ion of C12H22N2, with a mass error of 5 ppm.
The isotope pattern did not suggest the presence of chlorine or
sulfur in the molecule. Mass spectrometry and fragmentation
analyses suggested that the chemical consists of two alkyl
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chains and a cyclic moiety containing the two nitrogen atoms
(Fig. 5B). However, the predicted molecular formula could, in
theory, be generated by 3,316 potential distinct chemical struc-
tures according to Chemspider (http://www.chemspider.com/).
Therefore, repeated fractions containing this peak were
collected, pooled and subjected to NMR analysis (Fig. S7),
identifying the chemical as the ionic solvent 3-methyl-1-octyl-
1H-imidazol-3-ium+ (M8OI), see Fig. 5C for structure. Exposing
B-13 cells to the authentic commercially-available chloride salt
(M8OI-Cl) essentially replicated the toxicity of PBS 1 and 2
extracts in terms of effects on mitochondrial function (Fig. 6A)
including a clear dose-response effect on maximal respiration
and ATP production (Fig. 6B), ATP levels (Fig. 6C), caspase 3/7
activities (Fig. 6D), MTT reduction (Fig. S10A) and induction of
DNA nucleosomal laddering (Fig. 6E).
An approximate EC50% for MTT of 0.2% (v/v) for landfill PBS
extract 2 (Fig. 2C) and 50 lMM8OI for B-13 cells (Fig. S8B), sug-
gests that the concentration of M8OI in the PBS extract 2 was
approximately 25 mM.
B-13 cells also showed an increased sensitivity to M8OI com-
pared to the epithelial B-13/H cell in terms of mitochondrial
sensitivity (Fig. S8A), caspase 3/7 induction and loss of MTT
reduction activity (Fig. S8B), and the minimumM8OI concentra-
tion induced a detectable DNA ladder (Fig. S8C). M8OI was
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mildly toxic to the human cholangiocyte-like H69 cell line
(Fig. S9) based on MTT reduction assays (EC50% 500 lM com-
pared to 100 lM for B-13 cells).
These data indicate that soil samples surrounding a landfill
waste site contained the ionic liquid M8OI and that this chem-
ical is toxic to liver progenitor cells through an interaction with
their mitochondria, resulting in induction of apoptosis.
M8OI is metabolized to a carboxylate-containing metabolite
by human hepatocytes and is capable of being enzymatically
incorporated into the E2 component of pyruvate
dehydrogenase
Lipoic acid (structure in Fig. 7D) is a small endogenously syn-
thesized co-factor that is covalently bound to a variety of
enzymes, including the PDC-E2. This co-factor is essential for
the acyl or methylamine transfer functions of the enzymes to
which it is linked.10,11 Lipoic acid may be synthesized de novo
from octanoic acid produced during fatty acid synthesis in bac-
teria. There is also a scavenging pathway that links ATP or GTP
hydrolysis to its activation and conjugation to proteins25
(Fig. 7D).
Although M8OI is persistent it has been shown to be broken
down in the environment through oxidation of the terminal
carbon (C13) to form the carboxylic acid – 1-(7-carboxyheptyl)-
3-methyl-1H-imidazol-3-ium (COOH7IM).26 This pathway of
catabolism by soil bacteria mirrors the pathway of fatty acid
omega oxidation observed in mammalian liver (see Fig. S10B).
COOH7IM was not acutely toxic to B-13 cells (data not shown)
and therefore it was not directly tracked using our approach.
Therefore, its presence or absence in soil samples cannot be
determined with certainty.
To determine whether M8OI is metabolized to COOH7IM,
cultured human hepatocytes were exposed to M8OI for 24 h
prior to analysis by TripleTOF 5600 high-resolution quadrupole
time-of-flight mass spectrometry (Sciex). Mass spectrometric
scanning of predicted masses for the parent M8OI, hydroxylated
metabolite (HO8IM) and COOH7IM was used for detection and
to demonstrate that M8OI was metabolized to HO8IM and pre-
dominantly COOH7IM as predicted (Fig. 7A). Analysis of serum
samples isolated from mice orally administered M8OI demon-
strated that M8OI was absorbed from the gastrointestinal tract,
was systemically available and metabolized in the mouse like in
man, since both HO8IM and COOH7IM were detectable in sera
(Fig. 7B). Interestingly, M8OI was found to be present in bile
at levels >30-fold the concentrations found in sera (Fig. 7C),
indicating that a proportion of the chemical is cleared intact
via biliary excretion. COOH7IM was synthesized and its enzy-
matic incorporation into PDC-E2 examined. The covalent incor-
poration of lipoic acid into an unlipoylated fragment of the
human PDC-E2 protein (ULip) is shown (Fig. 7E), as previously
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Fig. 7. M8OI is metabolized to COOH7IM in human hepatocytes and mice and is enzymatically incorporated into an unlipoylated fragment of PDC-E2
in vitro. (A) Liquid chromatography-high resolution tandem mass spectrometry, using a TripleTOF 5600 high-resolution quadrupole time-of-flight mass
spectrometer (Sciex), analyses of three separate human hepatocyte cultures incubated with M8OI for 24 h prior to detection of M8OI, HO8IM and COOH7IM. (B)
Detection of M8OI in mouse sera orally exposed to control (left panels) or M8OI (right panels) in their drinking water as outlined in the methods section.
Position of HO8IM and COOH7IM peaks is indicated by arrows. (C) Mean and standard deviation concentration of M8OI in mouse sera and gall bladder bile in
control (three mice) and M8OI exposed mice (five mice). *Significantly different from control bile (p < 0.05) using the Student’s t test (two tailed). (D)
Illustration of two-step procedure for incorporation of LA into a ULip. (E) Western blot for the detection of ULip and Lip after addition of LA or COOH7IM, with
additions as indicated. LA, lipoic acid; LAE, lipoate activating enzyme; LT, lipoyl-AMP(GMP):N-lysine lipoyl transferase; ULip, unlipoylated fragment of PDC-E2;
Lip, lipoylated fragment of PDC-E2. (This figure appears in colour on the web.)
JOURNAL 
OF HEPATOLOGY
Journal of Hepatology 2018 vol. 69 j 1123–1135 1131
described.27 The incorporation of the M8OI derivative possess-
ing a carboxylated group on C13 (center panel, COOH7IM) was
also shown (Fig. 7E), an effect not observed with M8OI itself
nor an M8OI derivative possessing a hydroxyl group on C13
(i.e. HO8IM, data not shown). COOH7IM incorporation into ULip
was both GTP- and enzyme-dependent (Fig. 7E, right panel).
Discussion
This study initially aimed to determine the feasibility of extract-
ing chemicals from soil samples and applying them to a selected
suite of in vitro toxicity assays in order to screen for any toxico-
logical effects. The hypothesis was that the approach would
detect higher levels of chemicals with potential toxic effects
around a landfill site compared to sample sites not in proximity
to a landfill site. The presence of chemicals activating the AHR
was examined because this receptor is known to be activated
by PAHs associated with fossil fuel burning and industrial pollu-
tion.28 This receptor mediates most of the toxic effects of dioxin
in animals and man, including chloracne, anorexia, thymic atro-
phy and cancer.29 The AHR has also been shown to recognize
both xenobiotics and natural compounds (tryptophan metabo-
lites, dietary components and microbiota-derived factors), and
is important for maintenance of homeostasis at mucosal sur-
faces through regulation of type 3 innate lymphoid cells and T
helper 17 cell activities.30 The PPARa is the nuclear receptor
drug target for fibrate drugs that mediates reductions in lipid
levels through increasing peroxisomal oxidation of fatty acids.31
The presence of chemicals activating the PPARa was examined
because environmental surfactant pollutants (e.g. perfluoroalkyl
acids) activate this receptor.18 However, PPARa agonists have
also been shown to be protective against cholestatic liver
injury32 and are currently being considered as therapies for
PBC and other cholestatic liver diseases.33 One conclusion from
this study is that it is possible to readily detect chemicals from
soil extracts that contact and activate the receptors. The results
of our analyses indicate that the chemicals activating the AHR or
PPARa were widely present in the soils (either naturally and/or
through anthropomorphic activity), including soils not in close
proximity to a landfill site. Comparison of the potentially toxic
element content of these soils, based on metals and polyaro-
matic hydrocarbon (PAH) analyses, indicates that the soil sam-
ples are consistent with soils from urban areas in north east
England, and in most cases are lower than the mean for soils
in this region.34
In contrast, chemicals that activated the ERa were at higher
levels in soils around a landfill site compared to control soils. A
wide variety of man-made chemicals have been suggested to
have endocrine-disrupting chemicals in animals and
humans35,36 and many have been shown to have estrogenic
properties in that they mimic the biological effects of endoge-
nous estrogens (xenoestrogens). Therefore, in terms of disposal
of normal domestic waste, there may be a potential for xenoe-
strogens to be at higher levels in the surrounding environment,
although whether this is hazardous to the environment and to
nearby populations remains to be determined.
Given the marked toxic effect of two PBS extracts from two
sites in close proximity to a landfill site, the mechanism of
action and identity(ies) of the chemical(s) responsible were
investigated. Less potent effects were observed in B-13/H hepa-
tocytes derived from the B-13 progenitor (perhaps due to degra-
dation to less toxic metabolites in these more active xenobiotic
metabolizing cells) and a variety of other cells such as human
cholangiocytes. A single chemical was identified – the ionic
liquid 3-methyl-1-octyl-1H-imidazol-3-ium+ (M8OI) in the
toxic PBS extracts (which also contained estrogenic activity).
Since the pure commercially-available chemical induced the
same effects in B-13 cells, it is likely that the M8OI alone was
responsible for the effects of the toxic PBS extracts. Retrospec-
tive non-targeted data independent liquid chromatography-
high resolution tandem mass spectrometry analysis of all PBS
extracts confirmed that landfill sites 1 and 2 contained high
levels of M8OI (the highest – PBS extract 2, 2.4 mg/ml equal
to 12 mM) in good agreement with the estimation from toxicity
data of 25 mM. M8OI was present at low levels in all other
landfill sampling PBS extracts (range 0.0012–0.038 mg/L) but
not detected in any control sample sites. Based on these
analyses, and assuming that all M8OI partitioned into the PBS
extract, this means the highest M8OI soil concentration was
0.48 mmole/kg (equivalent to 94 mg/kg soil).
Ionic liquids are salts with a melting temperature below the
boiling point of water, are often liquids at room temperature
and are often composed of organic cations and inorganic
anions.37 They have been proposed to be a new generation of
‘‘green solvents” because they are organic solvents with rela-
tively low volatility. Therefore, they have many of the advan-
tages of molten salts without requiring high temperatures.37
The first ionic liquid was identified in the mid-19th century,
but the modern era of discovery and development occurred
with the generation of 1-butylpyridinium chloride–aluminium
chloride mixtures in the 1970s.38,37 They may currently find
use in protection products and herbicidal ionic liquids such as
derivatives of phenoxyacids exhibiting a selective herbicidal
activity against dicotyledonous plants.39 According to commer-
cial suppliers, M8OI is used/associated with metal plating,
electropolishing, metal reprocessing, phase transfer media, bat-
teries, nanomaterials, industrial solvents, nuclear fuel red waste,
enzymatic catalysis, lubricants, heat transfer and solar energy
conversion. Interrogation of the ECHA database shows that five
different M8OI salts have been pre-registered, but since no data
on their toxicity have been submitted, their production level by
any single producer should be less than 100 tonnes/annum
(Dr D Bell, ECHA, personal communication). However, it should
be noted that M8OI is one of many structurally-related ionic
liquids, some of which are used more widely.
A limited number of studies have been completed with salts
of M8OI, with only one study available to our knowledge in a
mammalian species in vivo. In this respect, the acute toxic
effects of 1-methyl-3-octylimidazolium bromide [M8IO+Br]
have been examined in mice. The study is limited to potential
adverse effects up to 24 h after i.p. administration with the
authors calculating an LD50% of 35.7 mg/kg body weight.40 The
authors report histopathological changes in the liver 10 h after
administration.
PBC is a chronic cholestatic liver disease characterized by clin-
ical chemical markers of periportal injury (e.g. raised serum ALP),
histopathological changes in the periportal region (intrahepatic
bile duct loss; mixed phenotype periportal inflammation and
fibrosis) and high serum titers of antibodies to antigens present
on the inner mitochondrial membrane (AMA).10,11 AMA is direc-
ted to the 2-oxoacid dehydrogenases complex family of enzymes
in over 95% of patients with PBC, likely through loss of tolerance
to the dihydrolipoamide acetyltransferase (E2) and/or enzyme 3
binding protein components of the pyruvate dehydrogenase
Research Article Cholestasis and Autoimmune Diseases
1132 Journal of Hepatology 2018 vol. 69 j 1123–1135
complex (i.e. PDC-E2 and PDC-E3BP respectively).41,10,11 There is
likely a genetic link to likelihood of developing PBC since there is
a sibling relative-risk of approx. 10.42 A number of polymor-
phisms have been associated with disease risk such as HLA-
DR8, with an odds ratio ranging from 2.4 to 3.3 depending on
the population examined.4 A number of other loci have been
identified by genome-wide association studies as influencing
disease risk, suggesting involvement of the innate and adaptive
immune systems and signaling via the NF-jB, toll-like receptor
and tumor necrosis factor pathways in PBC etiology.5 However,
there remains an environmental element to disease prevalence
(which might account in part for an apparent genetic association
to disease incidence because most families inhabit the same
environment). In this respect, epidemiological studies over the
last few decades have suggested a link between PBC incidence
and the reservoir source of drinking water;6 areas of heavy min-
ing;7 proximity to toxic landfill sites8 and exposure to chemicals,
such as those used in hair dyes.9 These observations have been
accompanied by a number of molecular studies which lend
weight to the potential for xenobiotics to be a trigger for PBC.
The first of these was the observation that the synthesis of pep-
tides in which the lipoate moiety had been replaced with xeno-
biotic lipoate mimics showed immunoreactivity to PBC patient
sera.43 Rabbits immunized with 6-bromohexanoate coupled to
bovine serum albumin (BSA), but not BSA-immunized controls,
developed AMA that was capable of inhibiting PDC-E2 enzymatic
function and binding to peptide sequences not present in the
xenobiotic carrier immunogen.44 2-Octynoic acid – used in cos-
metics – was first identified as a potential xenobiotic trigger
through screening 107 potential xenobiotic mimics coupled to
the lysine residue of the immunodominant 15 amino acid pep-
tide of the PDC-E2 inner lipoyl domain. PBC patient sera demon-
strated high Ig reactivity against 2-octynoic acid-PDC-E2
peptide.45 Optimal chemical structure of the xenobioticallymod-
ified epitope recognized by AMA-positive PBC sera was subse-
quently determined to be 2-nonynoic acid.46 However,
immunizing C57BL/6 mice with 2-octynoic acid coupled to BSA
resulted in autoimmune cholangitis; increased serum AMA;
increased liver lymphoid cell numbers; increases in CD8(+) liver
infiltrating cells, particularly CD8(+) T cells that co-express CD44
and an elevation in serum tumor necrosis factor-alpha and
interferon-gamma levels.47 Similar effects were also seen in a
non-obese diabetic (NOD) congenic strain.48 At the same time,
it was demonstrated that recombinant lipoylation enzymeswere
capable of aberrantly incorporating xenobiotic lipoic acid ana-
logues – including octanoic, hexanoic acids and the xenobiotic
6 bromohexanoic acid – into PDC-E2.27 More recent studies have
shown that AMA-positive PBC sera demonstrate reactivity to
xenobiotics that have lipoic acid covalentlymodified at the disul-
fide ring, therefore without replacing the lipoic acid.49 In both
early and late-stage PBC the predominant Ig isotype to 6,8-bis
(acetylthio) octanoic acid (SAc)-conjugated BSA was IgM, with
titers higher with advanced stage disease.50 However, whilst
these studies show that exposure to a haptenized xenobiotic
can give rise to immunological and pathological changes in ani-
mal models similar to the PBC in humans, none of the studies
have exposed animals to xenobiotic alone to produce these
effects.
It can be seen that M8OI bears some structural similarity to
lipoic acid and, if metabolized to a carboxylic acid (in the envi-
ronment and/or in the liver), has the potential to be incorpo-
rated into PDC-E2 in place of lipoic acid (Fig. S10B). It could
be envisaged that M8OI undergoes omega hydroxylation, which
would occur via hepatic cytochrome P450 hydroxylation of fatty
acids, followed by oxidation of the alcohol to a carboxylic acid.51
An additional factor that is likely to be important in disease
pathogenesis is the biliary route of excretion of these chemicals.
Preliminary data in this manuscript indicate that a proportion of
the intact toxic M8OI chemical passes into the bile and that con-
centrations may be significantly higher than those present in
serum.
This paper identifies, for the first time, a xenobiotic present
in the environment capable of being a potential xenobiotic trig-
ger for PBC. It remains to be determined whether M8OI is a sig-
nificant risk for triggering PBC, given its low production levels.
However, since M8OI is structurally-related to other more
widely used ionic liquids, there may be a hazard with these
chemicals relating to PBC. However, the suggestion that
structurally-related ionic liquids represent a risk for triggering
PBC remains hypothetical. A realistic assessment of risk may
be determined through exposing experimental animals more
extensively to these ionic liquids.
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